VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31

VIEMED HEALTHCARE, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026

$9.59+0.11 (+1.16%)

Close on Oct 19, 2026

Market cap: $394.40M
P/E (TTM): 26.6
Dividend yield: –

VIEMED HEALTHCARE, INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31
Revenue	270	224	183	139	117	131	80	64
Cost of Revenue	115	91	70	54	44	51	24	17
Gross Profit	155	133	113	85	73	80	56	48
Research & Development	3.02	3.07	2.78	2.70	2.11	1.08	0.85	0
Selling, General & Admin	121	106	88	68	55	53	41	34
Operating Income	23	18	14	8.25	12	27	8.86	10
Income from Equity Investments	0	-0.95	0.49	0.94	1.24	0.09	-0.11	–
Other Non-Operating Income	0.25	-0.17	0.10	0.99	1.62	3.95	0.00	–
Asset Impairment Charges	0	0	0	0	0	0	–	–
Gain (Loss) on Sale of Assets	2.24	1.91	-0.65	-0.35	-0.45	2.33	-0.36	-0.05
Pretax Income	22	16	14	8.99	13	26	8.80	9.67
Income Tax Expense	6.39	4.76	4.15	2.77	3.38	-5.17	0.27	0.16
Net Income incl. Noncontrolling Interests	15	11	10	6.22	–	–	–	–
Minority Interest in Earnings	0.44	0.14	0	0	–	–	–	–
Net Income	15	11	10	6.22	9.13	32	8.53	9.51
EPS (Basic)(per share)	0.38	0.29	0.27	0.16	0.23	0.81	0.23	0.25
EPS (Diluted)(per share)	0.37	0.28	0.25	0.16	0.22	0.78	0.21	0.24
Shares Outstanding (Basic, Weighted)(shares)	39	39	38	39	39	39	38	38
Shares Outstanding (Diluted, Weighted)(shares)	41	41	40	40	41	41	40	40
EBITDA	52	43	36	24	–	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 57.5%
Operating margin: 7.5%
Net margin: 4.8%
Return on equity, FY2025: 10.9%

Financial strength

Current ratio: 1.13
Debt to equity: 0.05
Debt to assets: 3.5%
Cash to current liabilities: 22.3%

Valuation

P/E ratio: 26.6
Price to sales: 1.31
Price to book: 2.74
Dividend yield: –